Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Disease

James Van Der Beek diagnosed with bowel cancer — what to know about the disease

As the former Dawson’s Creek star shares his diagnosis and says he’s ‘feeling good’, we ask a leading doctor for the facts on the disease — which is the fourth most common cancer in the UK

Evening Standard

Amy Dowden has made as much impact on awareness as on Strictly dancefloor

The Welsh dancer will not take part in the rest of the BBC dance competition this year while she recovers from a foot injury.

Evening Standard

5 symptoms women over 40 should always take seriously

The loss of these hormones, which are a normal part of aging for women, can have a systemic impact on health, especially cardiovascular health.

Fortune

From analysis to the latest developments in health,
read the most diverse news in one place.

Osteoporosis, the silent disease, can shorten your life − here’s how to prevent fractures and keep bones healthy

Because there are typically no symptoms until the first fracture occurs, osteoporosis is considered a silent disease. Some call it a silent killer.

The Conversation

Colorectal cancer can affect anyone: What is it and what are the symptoms?

James Van Der Beek shares six children with his wife Kimberly Van Der Beek

The Independent UK

Adults with congenial heart disease can get insights into their quality of life

Adults with congenital heart disease (CHD) can now gain vital insights into their long-term quality of life according to data from the Congenital Heart Initiative (CHI). Read further on Dynamite News:

Dynamite News

Thanks to Wall Street, Novo Nordisk Stock is Now a Buy

Novo Nordisk has lost about a quarter of its value since the end of June. Meanwhile, indications are that its diabetes and weight-loss drugs may be useful in fighting cardiovascular disease, arthritis, opioid and alcohol addiction, and Alzheimer's. Novo remains a leader in the sector, and is trading at a…

Barchart

Read news from The Economist, FT, and more,
with one subscription

"I was terrible at asking for help, I just didn’t know how to do it," Miranda Hart says as she speaks candidly about her struggles with chronic illness

Miranda Hart's new memoir candidly details her struggles with chronic illness

Woman & Home

Scientists dismayed as UK ministers clear way for gene editing of crops - but not animals

Advocates urge government to allow ‘precision breeding’ to combat disease, but RSPCA warns of ethical dangers

The Guardian - UK

Could your cough be walking pneumonia? Here are the symptoms of the spiking bacterial illness

Infections tend to be most common among older children and adolescents but in 2024 have been rampant among young children, the CDC says.

Fortune

3 Biotechnology Stocks With Promising Pipelines

With increasing chronic diseases, demand for personalized medicines, and adoption of AI, the biotech market is booming. Therefore, it could be wise to invest in solid biotech stocks Amgen (AMGN), Regeneron Pharmaceuticals (REGN), and Gilead Sciences (GILD) for substantial returns. Read more.

StockNews.com

Cancer drug goes out on a limb for cardiac patients

A drug used in cancer treatment has the potential to save the limbs of thousands of cardiac patients with blocked arteries, a study has found.

AAP

US lawmakers call on EPA to ban pesticide linked to Parkinson’s disease

Politicians say use of common yet toxic paraquat can’t be justified due to apparent health and environment risks

The Guardian - US

Glioblastoma: why immunotherapy may offer hope for brain cancer patients

Glioblastoma is the most common and deadliest form of brain cancer. Patients face a bleak prognosis – the average survival after diagnosis is between 12 and 15 months. And just 6.9% of patients survive beyond five years, making it one of the most poorly survived cancers.

The Conversation

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Abbott Surges After Avoiding Another 'Eye-Popping' Verdict In Baby Formula Trial

Abbott stock surged early Friday after a jury decided baby formula from Abbott and Mead Johnson are not responsible for a boy's disease.

The Independent UK

Mpox outbreak: How can UK travellers stay safe from the virus?

The UK Health Security Agency say the risk of mpox infection is ‘low for most travellers’

International Business Times

Climate Shifts And Urbanisation Drive Nepal Dengue Surge

Nepal is fighting a surge in dengue cases, a potentially deadly disease once unheard of in the country's high-altitude Himalayan regions, as climate change and urbanisation nurture fever-bringing mosquitoes in new zones.

The Conversation

From eye exams to blood tests and surgery: how doctors use light to diagnose disease

This is the next article in our ‘Light and health’ series, where we look at how light affects our physical and mental health in sometimes surprising ways. Read other articles in the series.

Get all your
news in one place.

100’s of premium titles.
One news app.

Evening Standard

Sugar restrictions in early life ‘may lower chronic disease risk in adulthood’

The findings are based on data gathered after the Second World War in the UK, around the time when sugar rationing ended.

Evening Standard

Blood test could ‘reliably rule out’ Alzheimer’s, trial finds

There are hopes it will offer reassurance to patients with cognitive decline and help them avoid unnecessary further testing, researchers said.

The Conversation

Alzheimer’s treatment donanemab is not a ‘miracle drug’ – not providing it on the NHS is the right choice

There was frustration in some corners of the media when it was announced that a new drug to slow the progression of Alzheimer’s was not going to be made available on the NHS.

Fortune

The world has a new leading infectious disease killer

A longtime leading killer retakes the lead.

LiveScience

Trigger for deadly neurodegenerative disorder identified

The discovery of an important enzyme involved in Huntington's disease may pave the way for future treatments to prevent the condition, researchers say.

The Independent UK

How worried should we be about the new mpox strain?

How worried should the UK public be about the new case of mpox identified in the UK? Health Correspondent Rebecca Thomas explains why the risk to the general population is currently very low

Investors Business Daily

Regeneron Takes A Ghastly Turn As High-Dose Eylea Lags And Biosimilars Loom

Regeneron stock toppled Thursday after the biotech giant reported lighter-than-expected sales of its new eye disease drug.

1 … 4 5 6 7

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.